Agilent Technologies, Inc. (A), Apple Inc. (AAPL), Adobe Inc. (ADBE), Akamai Technologies, Inc. (AKAM), Advanced Micro Devices, Inc. (AMD), ams-OSRAM AG (AMS, AMSSY, AUKUF), Amazon.com, Inc. (AMZN), Alibaba Group Holding Limited (BABA, BABAF), Coherent Corp. (COHR), Salesforce, Inc. (CRM), Corsair Gaming, Inc. (CRSR), CrowdStrike Holdings, Inc. (CRWD), Corteva, Inc. (CTVA), Fresenius Medical Care AG & Co. KGaA (FMS), The GEO Group, Inc. (GEO), Georg Fischer AG (GF, FCHRF), General Motors Company (GM), Alphabet Inc. (GOOG, GOOGL), Idorsia Ltd (IDIA, IDRSF), Intel Corporation (INTC), IQVIA Holdings Inc. (IQV), Intuitive Surgical, Inc. (ISRG), Kohl's Corporation (KSS), Logitech International S.A. (LOGN, LOGI), Lululemon Athletica Inc. (LULU), Meta Platforms, Inc. (META), Markel Group Inc. (MKL), Medical Properties Trust, Inc. (MPW), Microsoft Corporation (MSFT), NIKE, Inc. (NKE), NVIDIA Corporation (NVDA), Novartis AG (NOVN, NVS, NVSEF), Palo Alto Networks, Inc. (PANW), Paylocity Holding Corporation (PCTY), Philip Morris International Inc. (PM), PayPal Holdings, Inc. (PYPL), Roche Holding AG (ROGN, RHHBF, RHHBY, RHHVF), SAP SE (SAP), Block, Inc. (SQ), AT&T Inc. (T), Tesla, Inc. (TSLA), Taiwan Semiconductor Manufacturing Company Limited (TSM), CVR Partners, LP (UAN), Verizon Communications Inc. (VZ), Wix.com Ltd. (WIX), Zimmer Biomet Holdings, Inc. (ZBH), ZIM Integrated Shipping Services Ltd. (ZIM)
(the list is updated regularly)
Tesla Vs. General Motors: Which Stock Is The Better Investment?
This article focuses on long-term investment opportunities based on an in-depth fundamental analysis of two major players in the automotive industry. Tesla and General Motors are two prominent leaders in a highly competitive market, offering significant opportunities and reporting different risk profiles. I describe two valuation models structured around multiple scenarios to complete the analysis.
Novartis Is Awakening From Lethargy
Novartis is an outstanding dividend stock with an exciting potential in its stock price performance. In this article, I describe the advantageous risk-reward profile of Novartis for long-term investors while providing a comprehensive industry analysis including six peers and a DCF valuation model structured around multiple scenarios and finally giving a quick overview of the stock's actual technical situation.
SPY: 2008 Vs. 2022, Does History Repeat Itself?
In this market assessment article, I compare the situation of the SPY between 2008 and October 2022, the date the article was published, by focusing on the underlying conditions of the stock market.
Nvidia: A Setup That Cannot Be Ignored
In this article, based on technical analysis, I discuss essential price levels and metrics investors may consider to gain an overview of Nvidia stock's likely price action. I explain an actionable trading opportunity in the short term; I discuss a contingency plan with multiple outcomes and always examine the downside risk by considering appropriate stop-loss levels and actively managing the risk exposure.
Nike: After 48% Performance, It's Time For An Update
In this article, I discuss technical elements that underscore the increasingly high chances of seeing NKE's stock has peaked. As a follow-up article on a previously crafted fundamental analysis, I downgrade NKE stock to a hold position and discuss an optimistic scenario that could be interesting for both long- and short-term investors.